Facilitated subcutaneous immunoglobulin (fSCIg) therapy – practical considerations

There is an increasing range of therapeutic options for primary antibody-deficient patients who require replacement immunoglobulin. These include intravenous immunoglobulin (IVIg), subcutaneous immunoglobulin (SCIg), rapid push SCIg and most recently recombinant human hyaluronidase-facilitated SCIg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Exp Immunol
Main Authors: Ponsford, M, Carne, E, Kingdon, C, Joyce, C, Price, C, Williams, C, El-Shanawany, T, Williams, P, Jolles, S
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4636892/
https://ncbi.nlm.nih.gov/pubmed/26288095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12694
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados